We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has allotted Bonus shares to their existing members. Pursuant to ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Lifeline informed the exchange that its subsidiary, Trident Mediquip Limited (TML), has allotted 9,34,160 bonus shares to its existing members, with Trident Lifeline receiving these shares. Despite the bonus issuance, Trident Lifeline's shareholding in TML remains unchanged at 60.04% (both pre and post). TML operates in the pharmaceuticals and chemicals sector with a turnover of Rs. 21.29 crore in FY25 (vs Rs. 20.58 crore in FY24 and Rs. 28.77 crore in FY23). The bonus is being undertaken on an arm's length basis as it involves related parties including promoter group members.
Neutral for Trident Lifeline shareholders — the bonus is at the subsidiary level, so the parent's economic interest in TML stays at 60.04% with no dilution or accretion in value. This is a bookkeeping adjustment at the subsidiary and does not directly affect Trident Lifeline's per-share metrics.